The proteasome inhibitor Bortezomib sensitizes melanoma cells towards adoptive T cell attack

被引：0
|
作者：
Schmidt, P. [1 ,2 ]
Abken, H. [1 ,2 ]
机构：
[1] Univ Cologne, CMMC, D-5000 Cologne 41, Germany
[2] Univ Cologne, Dept Internal Med 1, D-5000 Cologne, Germany
来源：
HUMAN GENE THERAPY | 2010年 / 21卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1421 / 1422
页数：2
相关论文
共 50 条
  • [1] The Proteasome Inhibitor Bortezomib Sensitizes Melanoma Cells toward Adoptive CTL Attack
    Seeger, Jens Michael
    Schmidt, Patrick
    Brinkmann, Kerstin
    Hombach, Andreas A.
    Coutelle, Oliver
    Zigrino, Paola
    Wagner-Stippich, Diana
    Mauch, Cornelia
    Abken, Hinrich
    Kroenke, Martin
    Kashkar, Hamid
    [J]. CANCER RESEARCH, 2010, 70 (05) : 1825 - 1834
  • [2] Mir-34a Sensitizes Multiple Myeloma (MM) Cells to the proteasome Inhibitor Bortezomib
    Neri, Paola
    Johnson, Jordan
    Gratton, Kathy J.
    Ren, Li
    Duggan, Peter
    Stewart, Douglas A.
    Bahlis, Nizar
    [J]. BLOOD, 2011, 118 (21) : 66 - 67
  • [3] The proteasome inhibitor bortezomib sensitizes human tumor cells to TRAIL-mediated apoptosis
    Sayers, TJ
    Brooks, AD
    Ramirez, T
    Elliott, PJ
    Murphy, WJ
    [J]. JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 641 - 641
  • [4] Specific Cell-Permeable Inhibitor of Proteasome Trypsin-like Sites Selectively Sensitizes Myeloma Cells to Bortezomib and Carfilzomib
    Mirabella, Anne C.
    Pletnev, Alexandre A.
    Downey, Sondra L.
    Florea, Bogdan I.
    Shabaneh, Tamer B.
    Britton, Matthew
    Verdoes, Martijn
    Filippov, Dmitri V.
    Overkleeft, Herman S.
    Kisselev, Alexei F.
    [J]. CHEMISTRY & BIOLOGY, 2011, 18 (05): : 608 - 618
  • [5] The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo
    Ito, Keita
    Kobayashi, Masato
    Kuroki, Shiori
    Sasaki, Yu
    Iwata, Taisuke
    Mori, Kohei
    Kuroki, Tetsuya
    Ozawa, Yuta
    Tetsuka, Masanori
    Nakagawa, Tomoko
    Hiroi, Teruyo
    Yamamoto, Hitomi
    Ono, Kenichiro
    Washizu, Tsukimi
    Bonkobara, Makoto
    [J]. VETERINARY JOURNAL, 2013, 198 (03): : 577 - 582
  • [6] The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses
    Yanaba, Koichi
    Yoshizaki, Ayumi
    Muroi, Eiji
    Hara, Toshihide
    Ogawa, Fumihide
    Shimizu, Kazuhiro
    Sato, Shinichi
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 88 (01) : 117 - 122
  • [7] Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells
    Selimovic, Denis
    Porzig, Benjamin B. O. W.
    El-Khattouti, Abdelouahid
    Badura, Helene E.
    Ahmad, Mutmid
    Ghanjati, Foued
    Santourlidis, Simeon
    Haikel, Youssef
    Hassan, Mohamed
    [J]. CELLULAR SIGNALLING, 2013, 25 (01) : 308 - 318
  • [8] Effects of the proteasome inhibitor bortezomib on radiosensitivity of glioblastoma cells
    Forster, C.
    Schilling, D.
    Wank, M.
    Schmid, T. E.
    Combs, S. E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1281 - S1282
  • [9] Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel
    Mehdizadeh, Kayhan
    Ataei, Farangis
    Hosseinkhani, Saman
    [J]. MEDICAL ONCOLOGY, 2021, 38 (06)
  • [10] Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma
    Heider, Ulrike
    Rademacher, Jessica
    Lamottke, Britta
    Mieth, Maren
    Moebs, Markus
    von Metzler, Ivana
    Assaf, Chalid
    Sezer, Orhan
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (06) : 440 - 449
12345